DMAC
DiaMedica Therapeutics Inc.
Company Overview
| Mkt Cap | $350.97M | Price | $6.74 |
| Volume | 114.24K | Change | -0.88% |
| P/E Ratio | -14.4 | Open | $6.79 |
| Revenue | -- | Prev Close | $6.80 |
| Net Income | $-24.4M | 52W Range | $3.19 - $7.49 |
| Div Yield | N/A | Target | $12.33 |
| Overall | 49 | Value | 45 |
| Quality | 44 | Technical | 60 |
No chart data available
Stock Overview
Updated DailyDiaMedica Therapeutics Inc. (DMAC) is a leading Healthcare company in the Biotechnology industry, currently trading at $6.74 with a market capitalization of $350.97 million. The stock is trading near its 52-week highs, indicating strong momentum, demonstrating below-average quality metrics with a MarketXLS quality score of 44.
Today's trading session shows DMAC with a volume of 114K shares. The stock opened down 0.15% from yesterday's close of $6.80. Current analyst estimates project earnings of $-0.65 per share for this year, with next year targeting $-0.76.
DMAC demonstrates positive technical signals based on technical analysis. The company trades on the NSC exchange and operates alongside industry peers including OTIC, OTLC, OVAT-CA, ORTH-CA.
Key investment considerations for DMAC include below-average investment characteristics. The company offers a dividend yield of NA% and analyst price targets suggest potential upside of 82.9%. The stock shows elevated valuation levels based on valuation analysis.
Analysis generated on November 4, 2025 at 09:36 PM
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | DMAC | $6.74 | -0.9% | 114.24K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get DiaMedica Therapeutics Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW